Transfusion of incompatible blood to a patient with alloanti-Sc1.

Q4 Medicine Immunohematology Pub Date : 2023-06-01 DOI:10.21307/immunohematology-2023-011
C E George, S Grimsley, R Cumber, N Thornton, H Davies, C Harris, E Massey, K Perera
{"title":"Transfusion of incompatible blood to a patient with alloanti-Sc1.","authors":"C E George,&nbsp;S Grimsley,&nbsp;R Cumber,&nbsp;N Thornton,&nbsp;H Davies,&nbsp;C Harris,&nbsp;E Massey,&nbsp;K Perera","doi":"10.21307/immunohematology-2023-011","DOIUrl":null,"url":null,"abstract":"<p><p>Sc1 is a high-prevalence blood group antigen that is part of the Scianna blood group system. The clinical significance of Scianna antibodies is not well understood because of their rarity; there are only a handful of cases in the literature. This scarcity of information can make it difficult to decide on the best course of action when transfusing a patient with alloantibodies to Scianna blood group antigens. We describe a case of an 85-year-old woman presenting with melena and a hemoglobin of 66 g/L. Upon request for crossmatched blood, a panreactive antibody was found, later elucidated to be alloanti-Sc1. Because of the urgent nature of the transfusion, the patient was transfused with 2 incompatible, presumed Sc1+, red blood cell units with no evidence of an acute or delayed transfusion reaction. This case has been shared with the International Society of Blood Transfusion Rare Donor Working Party, via their Outcome of Incompatible Transfusion form, and adds to the body of evidence on clinical significance of antibodies to the antigens of the Scianna blood group system.</p>","PeriodicalId":13357,"journal":{"name":"Immunohematology","volume":"39 2","pages":"70-71"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunohematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21307/immunohematology-2023-011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Sc1 is a high-prevalence blood group antigen that is part of the Scianna blood group system. The clinical significance of Scianna antibodies is not well understood because of their rarity; there are only a handful of cases in the literature. This scarcity of information can make it difficult to decide on the best course of action when transfusing a patient with alloantibodies to Scianna blood group antigens. We describe a case of an 85-year-old woman presenting with melena and a hemoglobin of 66 g/L. Upon request for crossmatched blood, a panreactive antibody was found, later elucidated to be alloanti-Sc1. Because of the urgent nature of the transfusion, the patient was transfused with 2 incompatible, presumed Sc1+, red blood cell units with no evidence of an acute or delayed transfusion reaction. This case has been shared with the International Society of Blood Transfusion Rare Donor Working Party, via their Outcome of Incompatible Transfusion form, and adds to the body of evidence on clinical significance of antibodies to the antigens of the Scianna blood group system.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
输注异体抗sc1患者的不相容血液。
Sc1是一种高流行率的血型抗原,是山安娜血型系统的一部分。Scianna抗体的临床意义尚不清楚,因为它们很罕见;文献中只有少数案例。这种信息的缺乏使得在向携带Scianna血型抗原同种抗体的患者输血时,很难决定最佳的行动方案。我们描述了一个病例85岁的妇女呈现黑黑和血红蛋白66克/升。在交叉配血的要求下,发现了一种全反应性抗体,后来证实是同种异体抗sc1。由于输血的紧急性质,患者输了2个不相容的红细胞,推测为Sc1+,没有证据表明急性或延迟输血反应。该病例已与国际输血协会罕见献血者工作组分享,通过他们的不相容输血结果表,并增加了关于Scianna血型系统抗原抗体临床意义的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Immunohematology
Immunohematology Medicine-Medicine (all)
CiteScore
1.30
自引率
0.00%
发文量
18
期刊最新文献
A challenging case of hemolytic disease of the fetus and newborn (HDFN) due to anti-Ku in a K0 (Kellnull) mother. Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice. The American Rare Donor Program: 25 years supporting rare blood needs. Contents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1